INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.08 Million USD | 121.36% |
| 2022 | 490.67 Thousand USD | -87.78% |
| 2021 | 4.01 Million USD | 323.3% |
| 2020 | 948.52 Thousand USD | -29.24% |
| 2019 | 1.34 Million USD | 231.81% |
| 2018 | 404 Thousand USD | 75.51% |
| 2017 | 230.19 Thousand USD | 542.87% |
| 2016 | 35.8 Thousand USD | 823.1% |
| 2015 | 3879.00 USD | -56.45% |
| 2014 | 8906.00 USD | -45.96% |
| 2013 | 16.47 Thousand USD | -53.58% |
| 2012 | 35.49 Thousand USD | -33.76% |
| 2011 | 53.59 Thousand USD | 16.96% |
| 2010 | 45.82 Thousand USD | 110.06% |
| 2009 | 21.81 Thousand USD | -21.84% |
| 2008 | 27.9 Thousand USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 499.09 Thousand USD | 0.83% |
| 2024 Q2 | 744.61 Thousand USD | 49.19% |
| 2023 Q4 | 495 Thousand USD | 25.66% |
| 2023 Q1 | 275.47 Thousand USD | 38.46% |
| 2023 Q2 | 60.48 Thousand USD | -78.04% |
| 2023 FY | 1.08 Million USD | 121.36% |
| 2023 Q3 | 393.92 Thousand USD | 551.3% |
| 2022 Q3 | 126.2 Thousand USD | 371.56% |
| 2022 FY | 490.67 Thousand USD | -87.78% |
| 2022 Q4 | 198.94 Thousand USD | 57.64% |
| 2022 Q1 | 97.63 Thousand USD | -96.75% |
| 2022 Q2 | -46.47 Thousand USD | -147.6% |
| 2021 Q2 | 193.87 Thousand USD | -68.82% |
| 2021 Q3 | 198.45 Thousand USD | 2.36% |
| 2021 FY | 4.01 Million USD | 323.3% |
| 2021 Q4 | 3 Million USD | 1412.15% |
| 2021 Q1 | 621.77 Thousand USD | 233.62% |
| 2020 FY | 948.52 Thousand USD | -29.24% |
| 2020 Q3 | 308.67 Thousand USD | 37.25% |
| 2020 Q4 | 186.37 Thousand USD | -39.62% |
| 2020 Q2 | 224.9 Thousand USD | -1.61% |
| 2020 Q1 | 228.57 Thousand USD | -23.83% |
| 2019 FY | 1.34 Million USD | 231.81% |
| 2019 Q2 | 603.35 Thousand USD | 238.1% |
| 2019 Q1 | 178.45 Thousand USD | 60.59% |
| 2019 Q3 | 258.64 Thousand USD | -57.13% |
| 2019 Q4 | 300.08 Thousand USD | 16.02% |
| 2018 Q3 | 109.66 Thousand USD | 17.29% |
| 2018 FY | 404 Thousand USD | 75.51% |
| 2018 Q1 | 89.71 Thousand USD | 27.68% |
| 2018 Q4 | 111.12 Thousand USD | 1.33% |
| 2018 Q2 | 93.5 Thousand USD | 4.22% |
| 2017 Q4 | 70.26 Thousand USD | 26.85% |
| 2017 FY | 230.19 Thousand USD | 542.87% |
| 2017 Q3 | 55.39 Thousand USD | -16.24% |
| 2017 Q2 | 66.13 Thousand USD | 72.25% |
| 2017 Q1 | 38.39 Thousand USD | 497.68% |
| 2016 FY | 35.8 Thousand USD | 823.1% |
| 2016 Q4 | 6424.00 USD | -43.54% |
| 2016 Q3 | 11.37 Thousand USD | 271.31% |
| 2016 Q2 | 3064.00 USD | -79.49% |
| 2016 Q1 | 14.94 Thousand USD | 1002.29% |
| 2015 Q4 | -1656.00 USD | 12.8% |
| 2015 Q3 | -1899.00 USD | -137.35% |
| 2015 Q1 | 1417.00 USD | 0.0% |
| 2015 Q2 | 5085.00 USD | 258.86% |
| 2015 FY | 3879.00 USD | -56.45% |
| 2014 FY | 8906.00 USD | -45.96% |
| 2013 FY | 16.47 Thousand USD | -53.58% |
| 2012 FY | 35.49 Thousand USD | -33.76% |
| 2011 Q1 | 26.83 Thousand USD | 25.11% |
| 2011 Q2 | 15.42 Thousand USD | -42.51% |
| 2011 Q3 | 9619.00 USD | -37.64% |
| 2011 Q4 | 1715.00 USD | -82.17% |
| 2011 FY | 53.59 Thousand USD | 16.96% |
| 2010 FY | 45.82 Thousand USD | 110.06% |
| 2010 Q1 | 18.49 Thousand USD | 567.48% |
| 2010 Q4 | 21.44 Thousand USD | 1357.89% |
| 2010 Q2 | 7579.00 USD | -59.03% |
| 2010 Q3 | -1705.00 USD | -122.5% |
| 2009 Q3 | -830.00 USD | -107.94% |
| 2009 Q1 | 16.14 Thousand USD | -96.63% |
| 2009 FY | 21.81 Thousand USD | -21.84% |
| 2009 Q4 | -3957.00 USD | -376.75% |
| 2009 Q2 | 10.45 Thousand USD | -35.26% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | 479.34 Thousand USD | 0.0% |
| 2008 FY | 27.9 Thousand USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 134.623% |
| Cerus Corporation | 86.4 Million USD | 98.743% |
| OrthoPediatrics Corp. | 111.25 Million USD | 99.024% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -46.869% |
| Talis Biomedical Corporation | 371 Thousand USD | -192.76% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 86.868% |
| Inogen, Inc. | 126.69 Million USD | 99.143% |
| Spectral AI, Inc. | 7.88 Million USD | 86.217% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 116.477% |
| CVRx, Inc. | 33.03 Million USD | 96.713% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -1680.554% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.777% |
| Venus Concept Inc. | 52.16 Million USD | 97.918% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 57.406% |
| Bioventus Inc. | 328.19 Million USD | 99.669% |
| BrainsWay Ltd. | 23.09 Million USD | 95.296% |
| Envoy Medical, Inc. | -473 Thousand USD | 329.627% |
| electroCore, Inc. | 13.22 Million USD | 91.788% |
| IceCure Medical Ltd | 1.3 Million USD | 16.451% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 117.953% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 2394.528% |
| MaxCyte, Inc. | 36.54 Million USD | 97.028% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -137.918% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1176.908% |
| PAVmed Inc | -3.96 Million USD | 127.372% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 119.802% |
| RxSight, Inc. | 53.76 Million USD | 97.98% |
| Sight Sciences, Inc. | 69.17 Million USD | 98.43% |
| SI-BONE, Inc. | 109.42 Million USD | 99.007% |
| TELA Bio, Inc. | 40.11 Million USD | 97.292% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 93.172% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 99.285% |
| LivaNova PLC | 771.25 Million USD | 99.859% |
| 908 Devices Inc. | 25.32 Million USD | 95.711% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.65% |
| Nemaura Medical Inc. | -1.47 Million USD | 173.567% |
| NeuroPace, Inc. | 48.12 Million USD | 97.743% |
| LENSAR, Inc. | 21.1 Million USD | 94.854% |
| Apyx Medical Corporation | 14.12 Million USD | 92.309% |
| Cutera, Inc. | 41.49 Million USD | 97.382% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 94.117% |
| BioSig Technologies, Inc. | 18 Thousand USD | -5934.1% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 98.946% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 92.022% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.878% |
| Axonics, Inc. | 274.55 Million USD | 99.604% |
| Outset Medical, Inc. | 29 Million USD | 96.255% |
| IRIDEX Corporation | 21.8 Million USD | 95.019% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 98.471% |
| IRadimed Corporation | 50.15 Million USD | 97.835% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -278.445% |
| Telesis Bio, Inc. | 16.95 Million USD | 93.592% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 99.037% |
| Varex Imaging Corporation | 256.9 Million USD | 99.577% |
| Quipt Home Medical Corp. | 163.84 Million USD | 99.337% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 367.522% |
| Pulmonx Corporation | 50.75 Million USD | 97.86% |
| Dynatronics Corporation | 7.63 Million USD | 85.774% |
| Modular Medical, Inc. | -768 Thousand USD | 241.424% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 80.423% |
| Semler Scientific, Inc. | 61.2 Million USD | 98.225% |
| InMode Ltd. | 411.34 Million USD | 99.736% |
| Bruker Corporation | 1.51 Billion USD | 99.928% |
| Cytosorbents Corporation | 22.39 Million USD | 95.149% |
| DexCom, Inc. | 2.28 Billion USD | 99.953% |
| Align Technology, Inc. | 2.71 Billion USD | 99.96% |
| Viveve Medical, Inc. | 620 Thousand USD | -75.184% |
| ZimVie Inc. | 290.38 Million USD | 99.626% |
| Movano Inc. | -158 Thousand USD | 787.429% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 99.007% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1176.908% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.705% |
| Profound Medical Corp. | 4.51 Million USD | 75.939% |
| Insulet Corporation | 1.15 Billion USD | 99.906% |
| enVVeno Medical Corporation | -546 Thousand USD | 298.926% |
| Surmodics, Inc. | 93.05 Million USD | 98.833% |
| iCAD, Inc. | 14.53 Million USD | 92.528% |
| Nuwellis, Inc. | 4.98 Million USD | 78.203% |
| Biotricity, Inc. | 8.35 Million USD | 87.002% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.673% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 402.497% |
| InspireMD, Inc. | 1.8 Million USD | 39.893% |
| PAVmed Inc. | -3.96 Million USD | 127.372% |
| BIOLASE, Inc. | 16.72 Million USD | 93.506% |
| Beyond Air, Inc. | -1.3 Million USD | 183.102% |
| FONAR Corporation | 45.14 Million USD | 97.594% |
| AxoGen, Inc. | 127.87 Million USD | 99.151% |
| Vivani Medical, Inc. | -357 Thousand USD | 404.24% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.443% |
| Inari Medical, Inc. | 434.56 Million USD | 99.75% |
| UFP Technologies, Inc. | 112.22 Million USD | 99.032% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -8575.917% |
| Tenon Medical, Inc. | 1.24 Million USD | 12.479% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 1440.911% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 58.656% |
| AdaptHealth Corp. | 479.56 Million USD | 99.774% |
| Sintx Technologies, Inc. | 1.84 Million USD | 41.067% |
| NanoVibronix, Inc. | 1.53 Million USD | 29.334% |
| Quanterix Corporation | 70.64 Million USD | 98.463% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 367.522% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 92.275% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 97.942% |
| TransMedics Group, Inc. | 154.09 Million USD | 99.295% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 75.609% |
| NeuroMetrix, Inc. | 3.94 Million USD | 72.485% |
| Hyperfine, Inc. | 4.75 Million USD | 77.168% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 98.985% |
| Biomerica, Inc. | 611 Thousand USD | -77.764% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 97.395% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 239.078% |
| Silk Road Medical, Inc | 127.08 Million USD | 99.145% |